<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Hughes, E.G.</title>
    <link>http://repub.eur.nl/res/aut/10543/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis (Article)</title>
      <link>http://repub.eur.nl/res/pub/10266/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>A systematic review was conducted to determine whether initial screening
      characteristics of women with normogonadotrophic anovulatory infertility
      predict clinically significant outcomes of ovulation induction with
      gonadotrophins, and to obtain pooled estimates of their predictive value
      through meta-analysis. Only those studies in which pre-treatment screening
      characteristics (such as body mass index, serum LH and androgens, insulin
      sensitivity and ultrasound appearance of ovaries) were related to outcome
      parameters (such as total amount of FSH administered, cancellation,
      ovulation, pregnancy and miscarriage), were included in this analysis.
      Thirteen studies fulfilled the inclusion criteria. A positive association
      was seen in all studies between the level of obesity (definition applied
      as assessed by individual studies) and total amount of FSH administered
      [weighted mean difference (WMD) of 771 IU (95% confidence interval (CI):
      700-842)]. Pooled odds ratios (OR) of 1.86 (95% CI: 1.13-3.06) and 0.44
      (95% CI: 0.31-0.61) were found between obesity with cancellation and
      ovulation respectively. Pooled analysis did not show a significant
      association between obesity and pregnancy rate. The pooled OR for obese
      versus non-obese women and miscarriage rate was significant [3.05 (95% CI:
      1.45-6.44)]. Association measures between insulin resistance (definition
      applied as assessed by individual studies) and total amount of FSH
      administered produced a WMD of 351 (95% CI: 73-630) IU. A pooled OR of
      0.29 (95% CI: 0.10-0.80) was found for insulin resistance with pregnancy
      rate. The pooled OR for insulin resistance (hyperinsuliaemia versus
      normoinsuliaemia) and miscarriage rate was not significant. A pooled OR of
      1.04 (95% CI: 1.01-1.07) was found for LH (IU/l) with pregnancy rate. The
      pooled OR for LH and miscarriage rate was not significant. Finally, pooled
      analysis did not find a significant association between testosterone and
      pregnancy rate. In conclusion, the best available evidence, though
      limited, suggests that the most clinically useful predictors of
      gonadotrophin ovulation induction outcome in normogonadotrophic women are
      obesity and insulin resistance.</description>
    </item>
  </channel>
</rss>